(Q80429580)
Statements
Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system (English)
Anette L Eilertsen
Sigurd Liestøl
Marie-Christine Mowinckel
Per-Morten Sandset